As of Jan 23
| +0.21 / +3.45%|
The 3 analysts offering 12-month price forecasts for Apollo Endosurgery Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 9.50. The median estimate represents a +74.88% increase from the last price of 6.29.
The current consensus among 3 polled investment analysts is to Buy stock in Apollo Endosurgery Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.